Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00575562 · ClinicalTrials.gov registry record · Phase 1
Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer
A Phase 1 study, sponsored by Kyowa Kirin.
- Completed
- Registry status
- Phase 1
- Development phase
- 42
- Enrollment target
NCT00575562 is a Phase 1 study that has completed, run by Kyowa Kirin. The registered enrollment target is 42 participants.
The verdict
NCT00575562, a Phase 1 study, has completed, sponsored by Kyowa Kirin.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 42 participants
- Enrollment target
Study Summary
The primary objective of this study is to assess the safety and tolerability of KRN330 in patients with relapsed or refractory advanced or metastatic colorectal cancer.
Interventions
- DRUG KRN330
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2007-06 |
| Est. Completion | 2010-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00575562
The ClinicalTrials.gov registry entry for NCT00575562 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kyowa Kirin, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which KRN330 is the first listed.
NCT00575562 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00575562 about?
NCT00575562 is a clinical study titled "Phase I Study of KRN330 Monoclonal Antibody in Patients With Colorectal Cancer". The primary objective of this study is to assess the safety and tolerability of KRN330 in patients with relapsed or refractory advanced or metastatic colorectal cancer.
What is the current status of trial NCT00575562?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 42 participants. The study started on 2007-06. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00575562?
The interventions under investigation include: KRN330 (DRUG).
Who is sponsoring clinical trial NCT00575562?
This trial is sponsored by Kyowa Kirin, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.